Loading
Neurode, a Sydney-based company, secured $3.5 million in a pre-seed funding round. The investment was led by Khosla Ventures, with participation from PsyMed Ventures and Stoic VC. This funding occurred on September 10, 2024.
Neurode is developing a wearable headband designed to track and treat ADHD symptoms using light electrical stimulation in the prefrontal cortex. The company's technology aims to offer a non-drug treatment by measuring brain activity and delivering personalized electrical stimulation to improve focus and cognitive performance. The funds will be used to support clinical trials for the device, which is currently available through a private beta as Neurode plans to seek FDA approval.
Funding Round: Pre-Seed
Amount Raised: $3.5M
Valuation: Unknown
Lead Investor: Khosla Ventures
Other Funds that Invested: PsyMed Ventures
Company Industry: Medical Devices
Company Headquarters: Sydney, New South Wales, Australia
Join thousands of founders using our technology to find the right investors and close rounds faster than ever before.